# Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma

Source: [eLife: latest articles](https://elifesciences.org/articles/109124) · 2026-11-11 · Life
Page: https://themorning.science/story/multimodal-single-cell-analyses-reveal-distinct-fusion-regulated-transcriptional-f0ac01e6ac10a5dd
Kind: research · Impact: low

## In brief

- A multimodal single-cell study in Ewing sarcoma reports fusion-regulated transcriptional programs, according to an eLife article dated 2026-11-11.
- Ewing sarcoma is a fusion-driven malignancy that peaks in adolescence and is driven by EWS::FLI1 and related fusions.
- The source notes that patient outcomes vary greatly and asks whether tumor plasticity of EWS::FLI1-regulated signatures contributes to this variation.

## Why it matters

The study addresses why Ewing sarcoma outcomes differ between patients, which could inform future understanding of tumor heterogeneity and treatment response.

## Timeline

- 2026-11-11: eLife published the article Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma

## Coverage

- [Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma](https://elifesciences.org/articles/109124) — eLife: latest articles, 2026-11-11

Tags: ewing sarcoma, single-cell, transcriptomics, oncogenic fusion, tumor plasticity, cancer biology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science